| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former EVP, CCO | EVP, Chief Commercial Officer
1 company
Fiore Michael Henry serves as a Former EVP, CCO at HQY. Across recent SEC filings that breaks down to 0 buys and 7 sells. Those positions are worth an estimated $4.6M at current prices.
Historically, Fiore Michael Henry's trades have earned a below-average insider score of 43/100 across 3 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +0.3%.
The biggest single holding is HQY (~$4.6M) as Former EVP, CCO. The recent filings there lean toward selling, a net 20,422 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 2,354 | $95.00 | $223,630.00 | -4.3% | -1.4% | - | |
| Jul 2, 2026 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 2,470 | $95.00 | $234,650.00 | -4.2% | -7.2% | - | |
| May 29, 2026 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 3,142 | $95.00 | $298,490.00 | -5.0% | +6.1% | - | |
| Oct 7, 2025 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 1,781 | $88.21 | $157,102.01 | -3.5% | +5.6% | +3.8% | |
| Jul 7, 2025 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 1,794 | $101.73 | $182,498.91 | -3.3% | -13.8% | -6.4% | |
| Apr 4, 2025 | HQY Healthequity, Inc. | EVP, Chief Commercial Officer | Sell | 8,881 | $78.26 | $695,045.71 | -13.6% | +29.6% | +5.9% |